June 2008 | Oncology & Biotech News

Pegylated Liposomal Doxorubicin (Doxil) and Drug Combinations in Multiple Myeloma

June 10, 2010

Current treatment approaches for mutiple myeloma focus on improving progression-free and overall survival. Although five-year survival rates have increased significantly over the past ten years, the prognosis of the disease is generally poor. The availability of several promising new therapies offers clinicians treatment options to further improve response rates, especially through the development of new combination regimens.

ASCO Policy Change Creates Massive Avalanche of Pre-Meeting Data

June 09, 2010

When ASCO decision-makers decided to revise the manner in which they disseminate eagerly anticipated clinical research data, the news made headlines and reverberations that were felt throughout the worlds of oncology research, practice, finance, and investment.

The American Association for Cancer Research Annual Meeting

June 09, 2010

The American Association for Cancer Research (AACR), Philadelphia, is considered the world�s oldest and largest oncology-related scientific organization. Currently celebrating its centennial, the AACR recently held its 100th annual meeting at the San Diego Convention Center from April 12�16, 2008. The following sections provide a general overview of breaking news and session highlights from the conference.

Practical Information for the Community-Based Oncologist

June 09, 2010

This issue's cover story focuses on the 100th annual meeting of the American Association of Cancer Research held April 12-16 in San Diego,providing a general overview of breaking new and session highlights.